Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Augmedix (AUGX) Insider Trading & Ownership

Augmedix logo

Augmedix (NASDAQ:AUGX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.97%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$1.02 M
Get AUGX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Augmedix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AUGX Insider Buying and Selling by Quarter

Augmedix Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2024Emmanuel KrakarisCEOSell3,528$1.19$4,198.32  
5/15/2024Ian ShakilInsiderSell1,387$1.19$1,650.53  
5/15/2024Paul GinocchioCFOSell2,354$1.19$2,801.26  
5/15/2024Saurav ChatterjeeCTOSell1,767$1.19$2,102.73  
4/15/2024Ian ShakilInsiderSell500$3.80$1,900.00  
4/11/2024Ian ShakilInsiderSell24,778$3.93$97,377.54  
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
4/8/2024Ian ShakilInsiderSell37,780$3.97$149,986.60  
4/5/2024Ian ShakilInsiderSell51,387$4.03$207,089.61  
4/3/2024Ian ShakilInsiderSell45,906$4.11$188,673.66  
4/1/2024Ian ShakilInsiderSell58,978$3.91$230,603.98  
3/28/2024Ian ShakilInsiderSell31,994$4.06$129,895.64  
(Data available from 1/1/2013 forward)

AUGX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Augmedix includes Emmanuel Krakaris, Ian Shakil, Paul Ginocchio, and Saurav Chatterjee. Learn more on insiders at AUGX.

10.97% of Augmedix stock is owned by insiders. Learn more on AUGX's insider holdings.

The following insider purchased AUGX shares in the last 24 months: Paul Ginocchio ($48,500.00).

Insiders have purchased a total of 10,000 AUGX shares in the last 24 months for a total of $48,500.00 bought.

The following insiders have sold AUGX shares in the last 24 months: Emmanuel Krakaris ($4,198.32), Ian Shakil ($1,007,177.56), Paul Ginocchio ($2,801.26), and Saurav Chatterjee ($2,102.73).

Insiders have sold a total of 260,359 Augmedix shares in the last 24 months for a total of $1,016,279.87 sold.

Augmedix Key Executives

  • Mr. Emmanuel Krakaris (Age 65)
    President, CEO, Secretary & Director
    Compensation: $734.33k
  • Mr. Ian Shakil (Age 39)
    Founder, Chief Strategy Officer & Director
  • Ms. Sandra Breber (Age 66)
    Chief Operating Officer
    Compensation: $446.05k
  • Mr. Saurav Chatterjee Ph.D. (Age 52)
    Chief Technology Officer
    Compensation: $438.05k
  • Mr. Paul Louis Ginocchio (Age 54)
    Chief Financial Officer
  • Todd Holvick
    Head of Legal & Compliance
  • Lia Wallick
    Head of People
  • Dr. Davin Lundquist M.D.
    Chief Medical Officer
  • Mr. Jonathan Hawkins (Age 54)
    Chief Revenue Officer
    Compensation: $417.71k
  • Mr. Tomer Levy
    Senior Vice President of Engineering


This page (NASDAQ:AUGX) was last updated on 11/25/2024 by MarketBeat.com Staff
From Our Partners